Lifeward Ltd. Reports Q3 2025 Financial Results with Revenue Increase but Higher Net Loss

Lifeward Ltd. reported its financial results for the third quarter of 2025, revealing a revenue of $6.2 million, a slight increase from $6.1 million in the same period last year. For the nine months ending September 30, 2025, total revenue was $17.0 million, down from $18.1 million in the prior year. The company experienced a gross profit of $2.7 million for the quarter, compared to $2.2 million in Q3 2024, while the gross profit for the nine-month period increased to $7.3 million from $6.4 million. Despite these figures, Lifeward reported a net loss of $3.2 million for the quarter, slightly higher than the $3.1 million loss in Q3 2024, and a total net loss of $14.6 million for the nine months, compared to $13.7 million in the previous year.

The company’s financial position showed significant changes compared to the previous fiscal period. As of September 30, 2025, Lifeward's total assets decreased to $23.2 million from $30.5 million at the end of 2024. Cash and cash equivalents also fell sharply to $2.0 million from $6.7 million. The company’s accumulated deficit increased to $279.4 million, reflecting ongoing operational challenges. Lifeward's total liabilities decreased slightly to $10.4 million from $11.6 million, indicating some progress in managing its obligations.

Strategically, Lifeward has made notable developments, including the acquisition of AlterG, Inc. in August 2023, which has since been rebranded as Lifeward CA, Inc. This acquisition is expected to enhance Lifeward's product offerings in rehabilitation technology. The company continues to market its products, including the ReWalk and ReStore devices, directly to rehabilitation centers and through distributors in various regions, including the U.S., Germany, Canada, and Australia. Lifeward's product adoption rates remain a focus, as it aims to expand its market presence and improve sales through strategic partnerships.

Operationally, Lifeward reported a decrease in its workforce, which is part of its cost-reduction strategy amid ongoing financial challenges. The company’s cash flow from operations for the nine months ended September 30, 2025, was negative at $13.3 million, although it improved from a negative $17.7 million in the same period last year. Lifeward's management has indicated that it is exploring various financing options to support its operations and is considering potential workforce reductions and budget cuts to manage expenses effectively.

Looking ahead, Lifeward has expressed concerns regarding its ability to continue as a going concern, given its current financial situation and the need for additional funding. The company plans to raise capital through various financing efforts in the near term to meet its operational needs for the next 12 months. However, management has acknowledged the uncertainty surrounding these efforts, which could impact its strategic initiatives and market expansion plans. Lifeward's future performance will depend on its ability to stabilize its financial position and successfully integrate its recent acquisition while navigating the challenges posed by market conditions and operational costs.